BioLife Solutions (BLFS) Tops Q3 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $28.30 -1.29%
EPS Growth %: +109.1%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +109.1%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $28.07 million versus the consensus estimate of $25.69 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $95-96 million, versus the consensus of $101.3 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale
- FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
